A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society
Can J Cardiol. 1997 Jan;13(1):33-45.
[Article in
English,
French]
No abstract available
MeSH terms
-
Canada
-
Cardiology
-
Cardiovascular Agents / economics*
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / economics
-
Cost Control
-
Drug Costs
-
Humans
-
Prescription Fees / standards*
-
Quality of Health Care
-
Rate Setting and Review
-
Research
-
Societies, Medical